These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 34954778)

  • 41. The Aurolab Keratoprosthesis (KPro) versus the Boston Type I Kpro: 5-year Clinical Outcomes in 134 Cases of Bilateral Corneal Blindness.
    Basu S; Serna-Ojeda JC; Senthil S; Pappuru RR; Bagga B; Sangwan V
    Am J Ophthalmol; 2019 Sep; 205():175-183. PubMed ID: 30905723
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Long-Term Outcomes of the Boston Type I Keratoprosthesis in the Management of Corneal Limbal Stem Cell Deficiency.
    Aravena C; Bozkurt TK; Yu F; Aldave AJ
    Cornea; 2016 Sep; 35(9):1156-64. PubMed ID: 27387566
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Outcomes of the Boston type 1 and the Aurolab keratoprosthesis in eyes with limbal stem cell deficiency.
    Shanbhag SS; Senthil S; Mohamed A; Basu S
    Br J Ophthalmol; 2021 Apr; 105(4):473-478. PubMed ID: 32554443
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Boston type 1 keratoprosthesis for failed keratoplasty.
    Hager JL; Phillips DL; Goins KM; Kitzmann AS; Greiner MA; Cohen AW; Welder JD; Wagoner MD
    Int Ophthalmol; 2016 Feb; 36(1):73-78. PubMed ID: 25975459
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Time to achieve best postoperative visual acuity following Boston keratoprosthesis surgery.
    El-Khoury J; Mustafa M; Daoud R; Harissi-Dagher M
    Br J Ophthalmol; 2022 Jul; 106(7):929-934. PubMed ID: 33658233
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pars plana vitrectomy without adjuvant procedures for repair of primary rhegmatogenous retinal detachment.
    Schneider EW; Geraets RL; Johnson MW
    Retina; 2012 Feb; 32(2):213-9. PubMed ID: 21811205
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Primary rhegmatogenous retinal detachment - surgical methods and anatomical outcome.
    Haugstad M; Moosmayer S; Bragadόttir R
    Acta Ophthalmol; 2017 May; 95(3):247-251. PubMed ID: 27860442
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Long-term visual outcomes of the Boston type I keratoprosthesis in Canada.
    Szigiato AA; Bostan C; Nayman T; Harissi-Dagher M
    Br J Ophthalmol; 2020 Nov; 104(11):1601-1607. PubMed ID: 32066560
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Outcome of pars plana vitrectomy in patients with retinal detachments secondary to retinal vasculitis.
    Bansal R; Moharana B; Katoch D; Gupta V; Dogra MR; Gupta A
    Indian J Ophthalmol; 2020 Sep; 68(9):1905-1911. PubMed ID: 32823412
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Longer-term vision outcomes and complications with the Boston type 1 keratoprosthesis at the University of California, Davis.
    Greiner MA; Li JY; Mannis MJ
    Ophthalmology; 2011 Aug; 118(8):1543-50. PubMed ID: 21397948
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Outcomes of surgery for retinal detachment associated with proliferative vitreoretinopathy using perfluoro-n-octane: a multicenter study.
    Scott IU; Flynn HW; Murray TG; Feuer WJ;
    Am J Ophthalmol; 2003 Sep; 136(3):454-63. PubMed ID: 12967798
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Chronic hypotony associated with the Boston type 1 keratoprosthesis.
    Dokey A; Ramulu PY; Utine CA; Tzu JH; Eberhart CG; Shan S; Gelhbach PL; Akpek EK
    Am J Ophthalmol; 2012 Aug; 154(2):266-271.e1. PubMed ID: 22633347
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Retinal detachment after phakic intraocular lens implantation in severe myopic eyes.
    Jiang T; Chang Q; Wang X; Huang X
    Graefes Arch Clin Exp Ophthalmol; 2012 Dec; 250(12):1725-30. PubMed ID: 22476574
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Boston keratoprosthesis type 1 surgery: use of frozen versus fresh corneal donor carriers.
    Robert MC; Biernacki K; Harissi-Dagher M
    Cornea; 2012 Apr; 31(4):339-45. PubMed ID: 22269678
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Long-term Outcomes of Boston Type I Keratoprosthesis, and Efficacy of Amphotericin B and Povidone-Iodine in Infection Prophylaxis.
    Prabhasawat P; Chotikavanich S; Ngowyutagon P; Pinitpuwadol W
    Am J Ophthalmol; 2021 Dec; 232():40-48. PubMed ID: 34102154
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Outcomes of Recurrent Retinal Detachment Surgery following Pars Plana Vitrectomy for Rhegmatogenous Retinal Detachment.
    Ambiya V; Rani PK; Narayanan R; Balakrishnan D; Chhablani J; Jalali S; Tyagi M; Pappuru RR
    Semin Ophthalmol; 2018; 33(5):657-663. PubMed ID: 29125779
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pars plana vitrectomy compared with pars plana vitrectomy combined with scleral buckle in the primary management of noncomplex rhegmatogenous retinal detachment.
    Orlin A; Hewing NJ; Nissen M; Lee S; Kiss S; DʼAmico DJ; Chan RV
    Retina; 2014 Jun; 34(6):1069-75. PubMed ID: 24853687
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Surgical and visual outcomes of the type I Boston Keratoprosthesis for the management of aniridic fibrosis syndrome in congenital aniridia.
    Bakhtiari P; Chan C; Welder JD; de la Cruz J; Holland EJ; Djalilian AR
    Am J Ophthalmol; 2012 May; 153(5):967-971.e2. PubMed ID: 22265154
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Long-term Visual Outcomes and Complications of Boston Keratoprosthesis Type II Implantation.
    Lee R; Khoueir Z; Tsikata E; Chodosh J; Dohlman CH; Chen TC
    Ophthalmology; 2017 Jan; 124(1):27-35. PubMed ID: 27538795
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Combined cataract surgery and vitrectomy for recurrent retinal detachment.
    Chaudhry NA; Flynn HW; Murray TG; Belfort A; Mello M
    Retina; 2000; 20(3):257-61. PubMed ID: 10872930
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.